Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
Medtronic (MDT) Stock Price & Analysis
5,434 Followers
MDT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$67.11 - $87.96
Previous Close$77.61
Volume4.37M
Average Volume (3M)6.34M
Market Cap
$99.52B
Enterprise Value$116.74B
Total Cash (Recent Filing)$8.01B
Total Debt (Recent Filing)$25.02B
Price to Earnings (P/E)28.1
Beta0.76
Next Earnings
Aug 20, 2024EPS Estimate
$1.2Last Dividend Ex-Date
Jun 28, 2024Dividend Yield3.59%
Share Statistics
EPS (TTM)2.76
Shares Outstanding1,282,269,783
10 Day Avg. Volume6,316,846
30 Day Avg. Volume6,335,639
Standard Deviation0.07
R-Squared0.45
Alpha-0.00803
Financial Highlights & Ratios
Price to Book (P/B)-26.19
Price to Sales (P/S)12.19
Price to Cash Flow (P/CF)9.40
P/FCF Ratio10.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.61
Enterprise Value/Gross Profit5.52
Enterprise Value/Ebitda19.34
Forecast
1Y Price Target
$94.09Price Target Upside21.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Medtronic News
PremiumCompany Announcements
Medtronic CFO Transition and Interim Appointment Update
PremiumCompany Announcements
Medtronic Executive Retirement Signals Leadership Change
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMDT reported a headline beat driven by better showings across MedSurg, Neuroscience, and Diabetes.
Portfolio And Sales GrowthMDT's Portfolio Updates Were Favorable: The company anticipates F2025 sales growth for Cardiovascular, Medical Surgical and Neuroscience will track corporate-wide growth, while Diabetes sales should continue to grow above the corporate average.
Product LaunchesManagement's confidence that sales growth will remain solid stems from the recent and upcoming product launches.
Bears Say
Financial PerformanceAdjusted operating margin of 26.9% was below expectations, signaling ongoing supply chain pressures.
Management ChangesMDT announced the departure of its CFO, Karen Parkhill.
Market CompetitionMedtronic’s peers have been significantly increasing investments in the highest growth segments of the market.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
MDT FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $67.11 and its highest was $87.96 in the past 12 months.
What is Medtronic’s market cap?
Currently, no data Available
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is Aug 20, 2024 which is in 44 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on May 23, 2024. The company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.451 by $0.009.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a Quarterly dividend of $0.7 which represents an annual dividend yield of 3.59%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is $1.2.
How many shares outstanding does Medtronic have?
Medtronic has 1,282,269,800 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.46 in its last earnings report, beating expectations of $1.451. Following the earnings report the stock price went down -5.106%.
Which hedge fund is a major shareholder of Medtronic?
Among the largest hedge funds holding Medtronic’s share is First Eagle Investment Management LLC. It holds Medtronic’s shares valued at 821M.
---
Medtronic Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$94.09 (21.23% Upside)
$94.09 (21.23% Upside)
Blogger Sentiment
Bullish
MDT Sentiment 91%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.57%
12-Months-Change
Fundamentals
Return on Equity
7.23%
Trailing 12-Months
Asset Growth
-1.06%
Trailing 12-Months
Company Description
Medtronic
Founded in 1949, Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The company is headquartered in Dublin, Ireland.
---
MDT Company Deck
---
MDT Earnings Call
Q4 2024
0:00 / 0:00
---
MDT Net sales Breakdown
37.06% Cardiovascular
28.69% Neuroscience
27.01% Medical Surgical
7.24% Diabetes
---
MDT Stock 12 Month Forecast
Average Price Target
$94.09
▲(21.23% Upside)
Technical Analysis
Best Analysts Covering MDT
1 Year
1 Year Success Rate
18/22 ratings generated profit
1 Year Average Return
+14.60%
reiterated a buy rating 7 months ago
Copying Kristen Stewart's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +14.60% per trade.
---